EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence

Background: Few reports have described endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) for biliary lesions. In addition, adverse events were not completely examined in previous reports, due to the inclusion of cases in which biliary stents had already been placed. The present study a...

Full description

Bibliographic Details
Main Authors: Saori Onda, Takeshi Ogura, Yoshitaka Kurisu, Daisuke Masuda, Tatsushi Sano, Wataru Takagi, Shinya Fukunishi, Kazuhide Higuchi
Format: Article
Language:English
Published: SAGE Publishing 2016-05-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756283X15625584
id doaj-aa2da5cb99824cce95697d7425a1e03d
record_format Article
spelling doaj-aa2da5cb99824cce95697d7425a1e03d2020-11-25T04:01:00ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-283X1756-28482016-05-01910.1177/1756283X15625584EUS-guided FNA for biliary disease as first-line modality to obtain histological evidenceSaori OndaTakeshi OguraYoshitaka KurisuDaisuke MasudaTatsushi SanoWataru TakagiShinya FukunishiKazuhide HiguchiBackground: Few reports have described endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) for biliary lesions. In addition, adverse events were not completely examined in previous reports, due to the inclusion of cases in which biliary stents had already been placed. The present study aimed to investigate the diagnostic yield and adverse events of EUS-FNA for biliary lesions as the first-line diagnostic modality for consecutive prospectively registered patients. Methods: Inclusion criteria were as follows: (1) patients with suspected cholangiocarcinoma (CCA) based on computed tomography or other imaging modalities; (2) patients who had not previously undergone endoscopic retrograde cholangiopancreatography or EUS-FNA; (3) absence of surgically altered anatomy, such as Roux-en-Y anastomosis or duodenal obstruction caused by tumor invasion, through which an endoscope could not pass; and (4) provision of written informed consent to all procedures associated with the study. Results: A total of 47 consecutive patients with suspected CCA were registered to this study. Sensitivity and accuracy were 89% and 87%, respectively. On multivariate analysis, puncture site was the only factor associated with reduced diagnostic yield (hazard ration, 6.879; 95% confidence interval, 1.172–40.374; P = 0.033). Remarkably, no adverse events such as bleeding or bile leakage were associated with EUS-FNA in any of the 47 patients. Conclusions: Our results suggest that EUS-FNA can be safely performed for biliary disease without biliary stenting. Furthermore, this procedure may warrant use as the first-line diagnostic method, although our results need to be validated in future prospective studies.https://doi.org/10.1177/1756283X15625584
collection DOAJ
language English
format Article
sources DOAJ
author Saori Onda
Takeshi Ogura
Yoshitaka Kurisu
Daisuke Masuda
Tatsushi Sano
Wataru Takagi
Shinya Fukunishi
Kazuhide Higuchi
spellingShingle Saori Onda
Takeshi Ogura
Yoshitaka Kurisu
Daisuke Masuda
Tatsushi Sano
Wataru Takagi
Shinya Fukunishi
Kazuhide Higuchi
EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence
Therapeutic Advances in Gastroenterology
author_facet Saori Onda
Takeshi Ogura
Yoshitaka Kurisu
Daisuke Masuda
Tatsushi Sano
Wataru Takagi
Shinya Fukunishi
Kazuhide Higuchi
author_sort Saori Onda
title EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence
title_short EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence
title_full EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence
title_fullStr EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence
title_full_unstemmed EUS-guided FNA for biliary disease as first-line modality to obtain histological evidence
title_sort eus-guided fna for biliary disease as first-line modality to obtain histological evidence
publisher SAGE Publishing
series Therapeutic Advances in Gastroenterology
issn 1756-283X
1756-2848
publishDate 2016-05-01
description Background: Few reports have described endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) for biliary lesions. In addition, adverse events were not completely examined in previous reports, due to the inclusion of cases in which biliary stents had already been placed. The present study aimed to investigate the diagnostic yield and adverse events of EUS-FNA for biliary lesions as the first-line diagnostic modality for consecutive prospectively registered patients. Methods: Inclusion criteria were as follows: (1) patients with suspected cholangiocarcinoma (CCA) based on computed tomography or other imaging modalities; (2) patients who had not previously undergone endoscopic retrograde cholangiopancreatography or EUS-FNA; (3) absence of surgically altered anatomy, such as Roux-en-Y anastomosis or duodenal obstruction caused by tumor invasion, through which an endoscope could not pass; and (4) provision of written informed consent to all procedures associated with the study. Results: A total of 47 consecutive patients with suspected CCA were registered to this study. Sensitivity and accuracy were 89% and 87%, respectively. On multivariate analysis, puncture site was the only factor associated with reduced diagnostic yield (hazard ration, 6.879; 95% confidence interval, 1.172–40.374; P = 0.033). Remarkably, no adverse events such as bleeding or bile leakage were associated with EUS-FNA in any of the 47 patients. Conclusions: Our results suggest that EUS-FNA can be safely performed for biliary disease without biliary stenting. Furthermore, this procedure may warrant use as the first-line diagnostic method, although our results need to be validated in future prospective studies.
url https://doi.org/10.1177/1756283X15625584
work_keys_str_mv AT saorionda eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
AT takeshiogura eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
AT yoshitakakurisu eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
AT daisukemasuda eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
AT tatsushisano eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
AT watarutakagi eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
AT shinyafukunishi eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
AT kazuhidehiguchi eusguidedfnaforbiliarydiseaseasfirstlinemodalitytoobtainhistologicalevidence
_version_ 1724448058378289152